chevron-down Created with Sketch Beta.

Memorandum (GyneTech and Michael Bass)

As requested, I’ve preliminarily reviewed the Food and Drug Administration (FDA) Office of Inspector General’s case report in the above matter, met with the lead agent Special Agent (SA) Smith, and mapped out a plan of investigation. My analysis and plan are set forth below.

Access Exclusive Benefits

Members unlock unlimited content, networking opportunities, publications and more.

  • Litigation Section
Join Member Group